Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma

被引:18
作者
Houette, A. [1 ]
Gilain, L. [1 ]
Mulliez, A. [2 ]
Mom, T. [1 ]
Saroul, N. [1 ]
机构
[1] Ctr Hosp Univ, Serv ORL & Chirurg Face & Cou, BP 69, F-63003 Clermont Ferrand 1, France
[2] Ctr Hosp Univ, Delegat Rech Clin & Innovat, BP 69, F-63003 Clermont Ferrand 1, France
关键词
Sinonasal mucosal melanoma; Prognostic value; Staging systems; Overall survival; MALIGNANT-MELANOMA; NASAL CAVITY; HEAD; NECK; EXPERIENCE; SURVIVAL; NOSE;
D O I
10.1016/j.anorl.2016.05.008
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: Sinonasal mucosal melanoma is a rare disease associated with a very poor prognosis. The purpose of this study was to assess the prognostic value of the 2 staging systems published in the literature for these tumours: the American Joint Committee on Cancer (AJCC) Cancer Staging Manual for mucosal melanoma of the head and neck published in 2009 (7th edition) and the AJCC Cancer Staging Manual for cancers of the nasal cavity and paranasal sinuses published in 2002 (6th edition) and the prognostic value of tumour site, either limited to the nasal cavities or with paranasal sinus invasion. Methods: A retrospective study was conducted on 18 patients treated between August 1998 and June 2014. Each lesion was staged according to the AJCC Cancer Staging Manual 2002 and 2009 and the following data were collected: age, sex, tumour site, initial symptoms, treatment modalities, follow-up, recurrences and overall survival. Patient survival, from the date of discovery of the melanoma until death, was analysed by Kaplan-Meier survival curves and between-group comparison of survival was performed with a log rank test. Results: The mean age at diagnosis was 72 years (range: 54-94) and the cohort comprised 11 women and 7 men. The median overall survival was 80 months, the 1-year overall survival was 82.6% and the 5-year overall survival was 54.5%. The AJCC 2002 staging system presented a statistically significant prognostic value (P=0.0476), while no statistically significant prognostic value was observed for the AJCC 2009 staging system (P=0.108). Paranasal sinus invasion was significantly associated with a poor prognosis (P=0.0039). Conclusion: This study demonstrates the superiority of the non-specific AJCC 2002 Cancer Staging Manual. Medical and surgical management must take paranasal sinus invasion into account, as it constitutes a major prognostic factor. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:313 / 317
页数:5
相关论文
共 50 条
  • [31] Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry
    Lei, Xuan
    Zhang, Yiming
    Mao, Lianghao
    Jiang, Pan
    Huang, Yumeng
    Gu, Jia
    Tai, Ningzheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Prognostic Value of Lactate Dehydrogenase in Patients with Melanoma Treated with Pembrolizumab
    Popovic, Aleksandar
    Petkovic, Ivan
    Dimitrijevic, Aleksandra
    Jovic, Andrija
    ACTA DERMATOVENEROLOGICA CROATICA, 2023, 31 (02) : 86 - 91
  • [33] Primary Localization and Tumor Thickness as Prognostic Factors of Survival in Patients with Mucosal Melanoma
    Mehra, Tarun
    Groezinger, Gerd
    Mann, Steven
    Guenova, Emmanuella
    Moos, Rudolf
    Roecken, Martin
    Claussen, Claus Detlef
    Dummer, Reinhard
    Clasen, Stephan
    Naumann, Aline
    Garbe, Claus
    PLOS ONE, 2014, 9 (11):
  • [34] Prognostic Value Of The Preoperative Neutrophil To Lymphocyte Ratio In Patients With Sinonasal Squamous Cell Carcinoma
    Zhong, Bing
    Deng, Di
    Du, Jin-Tao
    Chen, Fei
    Liu, Ya-Feng
    Liu, Shi-Xi
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9733 - 9741
  • [35] Comprehensive analysis of prognostic value of lymph node staging classifications in patients with head and neck squamous cell carcinoma after cervical lymph node dissection
    Wen, Junmiao
    Wei, Ye
    Jabbour, Salma K.
    Xu, Tingting
    Wang, Yu
    Chen, Jiayan
    Wang, Jiazhou
    Hu, Chaosu
    Su, Fengtao
    Fan, Min
    Zhang, Zhen
    Lu, Xueguan
    EJSO, 2021, 47 (07): : 1710 - 1717
  • [36] Clinical Value of Radiographic Staging in Patients Diagnosed With AJCC Stage III Melanoma
    Pandalai, Prakash K.
    Dominguez, Francisco J.
    Michaelson, James
    Tanabe, Kenneth K.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (02) : 506 - 513
  • [37] The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma
    Murali, Rajmohan
    Moncrieff, Marc D.
    Hong, Jonathan
    Cooper, Caroline L.
    Shingde, Meena V.
    Samuel, David G.
    Thompson, John F.
    Scolyer, Richard A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (11) : 2992 - 2999
  • [38] Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients
    Cui, ChuanLiang
    Lian, Bin
    Zhou, Li
    Song, Xin
    Zhang, XiaoShi
    Wu, Di
    Chi, ZhiHong
    Si, Lu
    Sheng, XiNan
    Kong, Yan
    Tang, BiXia
    Mao, LiLi
    Wang, Xuan
    Li, SiMing
    Dai, Jie
    Yan, XieQiao
    Bai, Xue
    Balch, Charles M.
    Guo, Jun
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (08) : 2184 - 2192
  • [39] The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status
    Dogrusoz, Mehmet
    Bagger, Mette
    van Duinen, Sjoerd G.
    Kroes, Wilma G.
    Ruivenkamp, Claudia A. L.
    Bohringer, Stefan
    Andersen, Klaus Kaae
    Luyten, Gregorius P. M.
    Kiilgaard, Jens F.
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (02) : 833 - 842
  • [40] Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
    Stadler, Julia-Christina
    Keller, Laura
    Mess, Christian
    Bauer, Alexander T.
    Koett, Julian
    Geidel, Glenn
    Heidrich, Isabel
    Vidal-Y-Sy, Sabine
    Andreas, Antje
    Stramaglia, Carlotta
    Sementsov, Mark
    Haberstroh, Wiebcke
    Deitert, Benjamin
    Hoehne, Inka Lilott
    Reschke, Robin
    Haalck, Thomas
    Pantel, Klaus
    Gebhardt, Christoffer
    Schneider, Stefan W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)